Positive result for Genentech in breast cancer trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Genentech, a member of the Roche Group, has achieved primary endpoint of a significant improvement in HER2-po...Read more
Zytiga, Xtandi to dominate prostrate cancer market
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Prostate cancer is becoming increasingly common due to globally growing numbers of elderly men, and scientist...Read more
Genzyme multiple sclerosis drug gets TGA nod
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2012
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...Read more
Ex-Novartis employee arrested for fudging data
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2014
Singapore: A former employee of the Japanese drug maker Novartis, was arrested with allegations of data manipulation. So...Read more
Eisai receives positive opinion on epilepsy treatments in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
Eisai's UK subsidiary, Eisai Europe, has received a positive opinion from the European Medicines Agency's Committee for ...Read more
NDA for Lundbeck's vortioxetine with US FDA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012
Singapore: Takeda Pharmaceutical and H. Lundbeck A/S have submitted a new drug application (NDA) to the US Food and Drug...Read more
Novartis gets positive regulatory feedback for hive drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 28 Jan, 2014
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a po...Read more
FDA green signal for joint GSK-Pfizer HIV drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2013
Singapore: The US FDA has approved GSK and Pfizer-owned HIV dedicated firm, ViiV Healthcare's, Tivicay (dolutegravir) 50...Read more
FibroGen, Astellas start trial of anemia therapeutic agent
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: FibroGen and Japanese company Astellas Pharma have initiated the first clinical study in the phase III clinic...Read more
Antisense Therapeutics ties up with China CRO for trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2013
Singapore: Antisense Therapeutics, an Australian publicly listed biopharmaceutical drug discovery and development compan...Read more
Merck resubmits NDA for ezetimibe, atorvastatin
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 03 Jan, 2013
Singapore: US FDA has acknowledged the resubmission of a New Drug Application (NDA) for ezetimibe and atorvastatin table...Read more
Eli Lilly pipeline will counter patent cliff in 2014
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2013
Singapore: Eli Lilly and Company has outlined its strategies to face patent cliff expected in 2014. In a statement to in...Read more
BioPharma Asia: Is Asia ready to boost global drug pipeline?
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 17 Mar, 2014
Singapore: Asia share of global GDP, measured in purchasing power, has increased from 26.8 percent in 2001 to 33.8 perce...Read more
Novo Nordisk obesity drug trial confirms weight loss
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2013
Singapore: Novo Nordisk's 56-week double-blind phase IIIa clinical trial with liraglutide has shown that it has the pote...Read more
New TB cocktail drug holds great promise
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2012
Singapore: A novel anti-TB drug has generated encouraging results in a recent Phase II trial funded by the non-profit TB...Read more
Singapore univ prepares for trial of glaucoma drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2013
Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technologic...Read more
BioDuro opens discovery lab in Shanghai
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ab...Read more
FDA approves ZALTRAP for colorectal cancer
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 06 Aug, 2012
Singapore: Sanofi and Regeneron Pharmaceuticals have received US Food and Drug Administration (FDA) approval for ZALTRAP...Read more